Foundation Healthcare Climbs 16% as Stabilisation Manager Executes Buy Orders

Recovery After Weak Debut

Foundation Healthcare shares have climbed approximately 16 per cent since the start of the week, driven by stabilisation trades executed by UBS. The multi-speciality healthcare group's stock rose as much as 7.8 per cent on Thursday morning, July 23, reaching S$0.825 in early trading.

The counter had struggled after its Singapore Exchange mainboard debut on July 8, closing that first session at S$0.70, nearly 8 per cent below its initial public offering price of S$0.76. The IPO had attracted 3.8 times subscription, signalling investor interest, but opening-day selling pressure pushed the stock underwater.

Stabilisation Trades Underpin Rally

The recent climb began on Wednesday, with shares adding more than 15 per cent following disclosure of UBS stabilisation activity. According to filings, UBS purchased approximately 19.5 million shares across eight separate trades between July 8 and July 22.

The purchases were executed at varying price levels. UBS acquired roughly 10.9 million shares in a range between S$0.70 and S$0.76, a further 4.5 million shares between S$0.705 and S$0.735, and two million shares between S$0.73 and S$0.76. The stabilisation mechanism, standard in many IPOs, allows underwriters to support share prices during the immediate post-listing period by purchasing stock in the open market.

By Thursday's intraday peak, the stock had gained S$0.06 from Wednesday's close, briefly trading above the offer price for the first time since listing.

Singapore IPO Market Revives

Foundation Healthcare's listing forms part of a broader revival in Singapore's IPO market, which is emerging from several years of subdued activity. Five listings in the first half of 2026 raised approximately S$1.1 billion, a sharp increase from just one IPO in the equivalent period of both 2024 and 2025.

The 2026 cohort includes real estate investment trusts, technology firms, and event management companies. Three additional listings are expected to follow Foundation Healthcare's debut in the second half of the year.

Market participants have noted that the rebound reflects stronger investor confidence, supportive policy measures, and a more robust pipeline of issuers. Singapore and Hong Kong have both benefited from a return of risk appetite in regional equity markets, particularly among institutional investors seeking exposure to Asia-focused growth stories.

Risks Persist Amid Geopolitical Uncertainty

Despite the improved sentiment, analysts caution that geopolitical volatility and economic uncertainty remain headwinds. Trade tensions, regulatory shifts in major economies, and fluctuating interest rates continue to weigh on investor sentiment across the region.

The healthcare sector, however, has attracted sustained interest. Private healthcare operators in Asia are positioned to benefit from rising middle-class demand, aging populations, and increasing consumer focus on preventive care. Foundation Healthcare operates a network of multi-speciality clinics, positioning it within a segment that has seen steady growth across Southeast Asia.

Whether the stabilisation-driven rally can be sustained will depend on the company's ability to deliver on operational metrics and earnings guidance in the coming quarters. For now, the stock's recovery offers a measure of relief to investors who participated in the IPO and a test case for other issuers eyeing Singapore's reviving capital markets.